DiaTech Licenses Vanderbilt's Personalized Tumor Test

The company will use the microkinetic test to measure apoptosis and draft a therapeutic profile for chemotherapy.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories